# OnCo record paper-ampect-nab-sirolimus-pecoma-wagner-jco-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-ampect-nab-sirolimus-pecoma-wagner-jco-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-ampect-nab-sirolimus-pecoma-wagner-jco-2021" ;
  schema:name "AMPECT: nab-sirolimus for malignant perivascular epithelioid cell tumours"@en ;
  schema:description "Albumin-bound sirolimus shrank tumours in about four in ten patients with malignant PEComa, with responses lasting years and best results in tumours with TSC2 mutations, and became the first approved treatment for the disease."@en ;
  schema:url <https://onco.cc/key-papers/paper-ampect-nab-sirolimus-pecoma-wagner-jco-2021/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.21.01728>, <https://pubmed.ncbi.nlm.nih.gov/34637337/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.21.01728> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Wagner AJ, Ravi V, Riedel RF, et al." ;
  onco:cancers <https://onco.cc/cancers/pecoma/> ;
  onco:drugs <https://onco.cc/drugs/sirolimus-albumin-bound/> ;
  onco:trials <https://onco.cc/trials/ampect/> ;
  onco:journals <https://onco.cc/journals/jco/> .